[DPHARMA] QoQ TTM Result on 31-Dec-2010 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- 2.76%
YoY- -5.18%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 137,291 134,988 135,625 131,437 129,092 126,816 124,896 6.50%
PBT 35,500 35,995 36,493 35,410 35,413 34,460 35,638 -0.25%
Tax -6,509 -6,906 -7,030 -6,741 -7,514 -7,251 -7,252 -6.94%
NP 28,991 29,089 29,463 28,669 27,899 27,209 28,386 1.41%
-
NP to SH 28,991 29,089 29,463 28,669 27,899 27,209 28,386 1.41%
-
Tax Rate 18.34% 19.19% 19.26% 19.04% 21.22% 21.04% 20.35% -
Total Cost 108,300 105,899 106,162 102,768 101,193 99,607 96,510 7.97%
-
Net Worth 162,353 154,198 162,320 156,744 148,494 140,286 146,967 6.85%
Dividend
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Div 5,014 5,014 6,402 6,402 22,910 22,910 16,743 -55.20%
Div Payout % 17.30% 17.24% 21.73% 22.33% 82.12% 84.20% 58.98% -
Equity
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Net Worth 162,353 154,198 162,320 156,744 148,494 140,286 146,967 6.85%
NOSH 138,763 138,917 138,735 138,711 138,779 138,897 138,648 0.05%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin 21.12% 21.55% 21.72% 21.81% 21.61% 21.46% 22.73% -
ROE 17.86% 18.86% 18.15% 18.29% 18.79% 19.40% 19.31% -
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 98.94 97.17 97.76 94.76 93.02 91.30 90.08 6.44%
EPS 20.89 20.94 21.24 20.67 20.10 19.59 20.47 1.36%
DPS 3.61 3.61 4.61 4.61 16.50 16.50 12.06 -55.21%
NAPS 1.17 1.11 1.17 1.13 1.07 1.01 1.06 6.79%
Adjusted Per Share Value based on latest NOSH - 138,711
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
RPS 14.27 14.03 14.10 13.66 13.42 13.18 12.98 6.51%
EPS 3.01 3.02 3.06 2.98 2.90 2.83 2.95 1.35%
DPS 0.52 0.52 0.67 0.67 2.38 2.38 1.74 -55.26%
NAPS 0.1688 0.1603 0.1687 0.1629 0.1544 0.1458 0.1528 6.85%
Price Multiplier on Financial Quarter End Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 -
Price 2.10 2.34 2.35 2.39 2.44 2.45 2.40 -
P/RPS 2.12 2.41 2.40 2.52 2.62 2.68 2.66 -14.02%
P/EPS 10.05 11.17 11.07 11.56 12.14 12.51 11.72 -9.73%
EY 9.95 8.95 9.04 8.65 8.24 8.00 8.53 10.80%
DY 1.72 1.54 1.96 1.93 6.76 6.73 5.03 -51.06%
P/NAPS 1.79 2.11 2.01 2.12 2.28 2.43 2.26 -14.38%
Price Multiplier on Announcement Date
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Date 21/11/11 18/08/11 25/05/11 23/02/11 26/11/10 24/08/10 25/05/10 -
Price 2.10 2.22 2.57 2.45 2.38 2.45 2.38 -
P/RPS 2.12 2.28 2.63 2.59 2.56 2.68 2.64 -13.59%
P/EPS 10.05 10.60 12.10 11.85 11.84 12.51 11.62 -9.21%
EY 9.95 9.43 8.26 8.44 8.45 8.00 8.60 10.19%
DY 1.72 1.63 1.79 1.88 6.93 6.73 5.07 -51.32%
P/NAPS 1.79 2.00 2.20 2.17 2.22 2.43 2.25 -14.13%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment